Citadel Advisors’s ADC Therapeutics ADCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.7K | Buy |
+29,006
| New | +$77.7K | ﹤0.01% | 5344 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 5876 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 5909 |
|
|
2024
Q3 | – | Sell |
-41,433
| Closed | -$131K | – | 5722 |
|
|
2024
Q2 | $131K | Sell |
41,433
-911,031
| -96% | -$2.88M | ﹤0.01% | 4843 |
|
|
2024
Q1 | $4.28M | Sell |
952,464
-900,948
| -49% | -$4.05M | ﹤0.01% | 1872 |
|
|
2023
Q4 | $3.08M | Sell |
1,853,412
-1,044,709
| -36% | -$1.73M | ﹤0.01% | 2041 |
|
|
2023
Q3 | $2.6M | Sell |
2,898,121
-271,728
| -9% | -$244K | ﹤0.01% | 2162 |
|
|
2023
Q2 | $6.82M | Sell |
3,169,849
-196,855
| -6% | -$423K | ﹤0.01% | 1480 |
|
|
2023
Q1 | $6.57M | Buy |
3,366,704
+1,378,836
| +69% | +$2.69M | ﹤0.01% | 1609 |
|
|
2022
Q4 | $7.63M | Buy |
1,987,868
+1,948,077
| +4,896% | +$7.48M | ﹤0.01% | 1472 |
|
|
2022
Q3 | $192K | Buy |
+39,791
| New | +$192K | ﹤0.01% | 4873 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5944 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6267 |
|
|
2021
Q4 | – | Sell |
-19,346
| Closed | -$525K | – | 6380 |
|
|
2021
Q3 | $525K | Sell |
19,346
-4,653
| -19% | -$126K | ﹤0.01% | 4477 |
|
|
2021
Q2 | $584K | Buy |
23,999
+8,837
| +58% | +$215K | ﹤0.01% | 4568 |
|
|
2021
Q1 | $370K | Sell |
15,162
-69,736
| -82% | -$1.7M | ﹤0.01% | 4841 |
|
|
2020
Q4 | $2.72M | Buy |
+84,898
| New | +$2.72M | ﹤0.01% | 2276 |
|
|
2020
Q3 | – | Sell |
-29,738
| Closed | -$1.39M | – | 4616 |
|
|
2020
Q2 | $1.39M | Buy |
+29,738
| New | +$1.39M | ﹤0.01% | 2559 |
|